Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Thurman

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Phase I and pharmacokinetic study of GI147211, a water-soluble camptothecin analogue, administered for five consecutive days every three weeksS G Eckhardt, S D Baker, J R Eckardt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Phase I and pharmacologic study of the tyrosine kinase inhibitor SU101 in patients with advanced solid tumorsS G Eckhardt, J Rizzo, K R Sweeney, et al.
The Journal of Infectious Diseases|September 24, 2008
Community outbreak of Mycoplasma pneumoniae infection: school-based cluster of neurologic disease associated with household transmission of respiratory illnessNicholas D Walter, Gavin B Grant, Utpala Bandy, et al.
European Journal of Medicinal Chemistry|May 28, 2026
Structure-guided design of broad-spectrum inhibitors of coronaviral proteases embodying a 1,3,2-oxazaphospholidin-3-one scaffold as a versatile design elementHarry Nhat Nguyen, Pulini S Ranasinghe, I Kankanamge Ravindu S Ilesinghe, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Phase I and pharmacokinetic study of GI147211, a water-soluble camptothecin analogue, administered for five consecutive days every three weeksS G Eckhardt, S D Baker, J R Eckardt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Phase I and pharmacologic study of the tyrosine kinase inhibitor SU101 in patients with advanced solid tumorsS G Eckhardt, J Rizzo, K R Sweeney, et al.
The Journal of Infectious Diseases|September 24, 2008
Community outbreak of Mycoplasma pneumoniae infection: school-based cluster of neurologic disease associated with household transmission of respiratory illnessNicholas D Walter, Gavin B Grant, Utpala Bandy, et al.
European Journal of Medicinal Chemistry|May 28, 2026
Structure-guided design of broad-spectrum inhibitors of coronaviral proteases embodying a 1,3,2-oxazaphospholidin-3-one scaffold as a versatile design elementHarry Nhat Nguyen, Pulini S Ranasinghe, I Kankanamge Ravindu S Ilesinghe, et al.
Pageof 7